Stalevo 150 Prices, Coupons and Patient Assistance Programs
Stalevo 150 (carbidopa/entacapone/levodopa) is a member of the dopaminergic antiparkinsonism agents drug class and is commonly used for Parkinson's Disease.
Stalevo 150 Prices
The cost for Stalevo 150 oral tablet (37.5 mg-200 mg-150 mg) is around $808 for a supply of 100 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
A generic version of Stalevo 150 is available, see carbidopa/entacapone/levodopa prices.
This Stalevo 150 price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Stalevo 150 Coupons and Rebates
Stalevo 150 offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Stalevo 150
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about Stalevo 150 (carbidopa / entacapone / levodopa)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 1 Review
- Generic Availability
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (4)